| 2023 | | A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers | 은정우, 정재연 |
| 2019 | | A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status | 김순선, 김진홍, 노충균, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조효정, 황재철 |
| 2023 | | Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma | 김봉완, 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2013 | | Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection. | 정재연, 조성원 |
| 2014 | | Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma. | 정재연, 조성원 |
| 2012 | | Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients | 정재연, 조성원 |
| 2023 | | Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib | 김석휘, 김순선, 김영배, 은정우, 임수빈, 정재연, 조효정 |
| 2023 | | Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 김봉완, 김순선, 김영배, 김재근, 양민재, 왕희정, 유병무, 이광재, 이제희, 정재연, 조성원, 조혜성, 조효정 |
| 2017 | | Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver | 강대용, 김보현, 김순선, 김재근, 신성재, 유병무, 이광재, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2021 | | Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study | 김순선, 정재연 |
| 2021 | | Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers | 김순선, 은정우, 정재연, 조효정 |
| 2019 | | Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma | 김순선, 노충균, 신성재, 은정우, 이기명, 정재연, 조효정 |
| 2014 | | Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis. | 김순선, 안선주, 임선교, 정재연, 조성원, 황재철 |
| 2023 | | Efficacy of Co-Medications in Patients with Alcoholic Liver Disease | 박래웅, 정재연 |
| 2018 | | EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma | 김봉완, 김순선, 김영배, 노진, 노충균, 양민재, 왕희정, 윤소영, 이길호, 정재연, 조성원, 조효정, 황재철 |
| 2020 | | Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |
| 2019 | | HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma | 왕희정, 은정우, 정재연 |
| 2021 | | Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Radiologic and clinical factors predictive of survival | 권요한, 김재근, 김진우, 원제환, 조효정, 허지미 |
| 2023 | | Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly | 김순선 |
| 1999 | | Hepatocellular carcinoma with tumor thrombi in the bile duct. | 김명욱, 김욱환, 김진홍, 왕희정 |
| 2015 | | High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. | 김봉완, 김순선, 김재근, 노충균, 신성재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2017 | | Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib | 김보현, 김순선, 김재근, 신성재, 양민재, 유병무, 이광재, 이기명, 이제희, 임선교, 정재연, 조성원, 조효정, 황재철 |
| 2022 | | Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma | 강호철, 김순선, 은정우, 정재연, 조효정 |
| 2016 | | Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma | 김봉완, 김순선, 김영배, 왕희정, 정재연, 조성원 |
| 2018 | | Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B | 김순선, 박래웅, 양민재, 정재연, 조성원, 조효정 |
| 2021 | | Independent risk factors for hepatocellular carcinoma recurrence after direct-acting antiviral therapy in patients with chronic hepatitis C | 김순선, 박범희, 정재연, 조효정 |
| 2014 | | Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 신성재, 안선주, 유병무, 이기명, 정재연, 조성원, 조효정 |
| 2012 | | Interleukin-1ß and interleukin-1 receptor accessory protein gene polymorphisms are associated with persistent hepatitis B virus infection | 김순선, 정재연, 조성원 |
| 2015 | | Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. | 강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2020 | | Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma | 김보현, 김순선, 김재근, 이제희, 정재연, 조효정, 허지미 |
| 2020 | | Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment | 김보현, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미 |
| 2018 | | Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance | 김순선, 정재연 |
| 2017 | | Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment | 강대용, 김보현, 김봉완, 김순선, 김재근, 신성재, 양민재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정, 황재철 |
| 2015 | | Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. | 김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정 |
| 2020 | | Management of liver diseases during the pandemic of coronavirus disease-19 | 김순선 |
| 2020 | | MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma | 김순선, 우현구, 은정우, 정재연, 조효정, 최지혜 |
| 2005 | | MR findings in eosinophilic infiltration of the liver. | 김영배, 김재근, 선주성, 원제환, 이기명, 정재연 |
| 2021 | | Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer | 은정우 |
| 2016 | | Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis | 조성원 |
| 2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
| 2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
| 2013 | | Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence. | 정재연, 조성원 |
| 2020 | | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | 김순선, 정재연 |
| 2014 | | Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma. | 김순선, 안선주, 우현구, 정재연, 조성원, 조효정 |
| 2014 | | Prognostic significance of catalase expression and its regulatory effects on hepatitis B virus X protein (HBx) in HBV-related advanced hepatocellular carcinomas. | 왕희정, 이영수, 정재연, 조혜성 |
| 2021 | | Prognostic value of alpha-fetoprotein in patients who achieve a complete response to transarterial chemoembolization for hepatocellular carcinoma | 김순선, 정재연, 조효정 |
| 2013 | | Radiofrequency ablation of metastatic liver masses: recurrence patterns and prognostic factors based on radiologic features. | 김재근, 김태희, 박미진, 이기명, 정재연 |
| 2023 | | Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection | 김순선 |
| 2015 | | Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population. | 정재연, 조성원 |
| 2023 | | Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis | 김순선 |
| 2022 | | Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma | 김봉완, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미 |
| 2021 | | Role of immune cells in patients with hepatitis b virus‐related hepatocellular carcinoma | 정재연, 조효정 |
| 2020 | | Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2019 | | Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial | 정재연 |
| 2014 | | Surgical outcomes for solid pseudopapillary neoplasm of the pancreas. | 김욱환, 김지훈, 김진홍, 백남현, 유병무, 황재철 |
| 1999 | | Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma. | 김영수, 박찬희, 왕희정, 이광재, 임현이, 조성원, 진윤미, 함기백 |
| 2020 | | Treatment and prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2014 | 김순선, 노오규, 양민재, 임선교, 정재연, 조효정, 황재철 |
| 2021 | | Update on liver disease management during the pandemic of coronavirus disease 2019 (Covid-19): 2021 kasl guideline | 김순선 |
